Document Detail


Molecular mechanisms of band 3 inhibitors. 3. Translocation inhibitors.
MedLine Citation:
PMID:  3801448     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During the translocation of the band 3 transport site between the inward- and outward-facing orientations, the Cl- transport site complex passes through a transition state lying on the reaction pathway between the two extreme orientations. Niflumic acid, 2-[(7-nitrobenzofurazan-4-yl)amino]ethanesulfonate, and 2,4,6-trichlorobenzenesulfonate each are translocation blockers that can bind to both the inward- and outward-facing conformations of band 3. The principal mechanism of these inhibitors is a reduction in the translocation rate, since they have essentially no effect on the apparent KD for Cl- binding to the transport site and the migration of Cl- between the transport site and solution. Instead, these inhibitors raise the free energy of formation of the transition state during translocation and thereby can lock the transport site into either the inward- or outward-facing orientation. In contrast, 2,4-dinitrofluorobenzene (DNFB) appears to restrict the accessibility of the transport site to solution Cl-; also, the DNFB reaction rate is increased by Cl-, suggesting that DNFB modification may occur during translocation. Thus DNFB is proposed to trap the Cl--transport site complex site during translocation to yield a conformation intermediate to the inward- and outward-facing orientations. A model is presented for the molecular mechanism of transport across biological membranes. The transport machinery is proposed to contain greater than or equal to 6 transmembrane helices that surround a central channel containing a sliding hydrophobic barrier. The transport site lies between two of the channel-forming helices and remains stationary while the hydrophobic barrier slides from one end of the channel to the other, thereby exposing the transport site to the opposite solution compartment.
Authors:
J J Falke; S I Chan
Related Documents :
20851348 - Metabolomic identification of the target of the filopodia protrusion inhibitor glucopie...
18316408 - Systematic kinetic analysis of mitotic dis- and reassembly of the nuclear pore in livin...
15557318 - Promiscuity in the geometry of electrostatic interactions between the escherichia coli ...
16413778 - Discovery of novel and selective tertiary alcohol containing inhibitors of the norepine...
23103508 - Model for β-1,6-n-acetylglucosamine oligomer hydrolysis catalysed by dispersinb, a bio...
17380198 - Structure and enzymatic functions of human cd38.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biochemistry     Volume:  25     ISSN:  0006-2960     ISO Abbreviation:  Biochemistry     Publication Date:  1986 Dec 
Date Detail:
Created Date:  1987-03-20     Completed Date:  1987-03-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370623     Medline TA:  Biochemistry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  7899-906     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anion Exchange Protein 1, Erythrocyte / antagonists & inhibitors*
Benzenesulfonates / pharmacology*
Biological Transport, Active / drug effects
Chlorides / blood*
Dinitrofluorobenzene / pharmacology
Erythrocyte Membrane / drug effects,  metabolism
Humans
Kinetics
Models, Biological
Nicotinic Acids / pharmacology*
Niflumic Acid / pharmacology*
Oxadiazoles / pharmacology*
Taurine / analogs & derivatives*,  pharmacology
Grant Support
ID/Acronym/Agency:
GM 22432/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Anion Exchange Protein 1, Erythrocyte; 0/Benzenesulfonates; 0/Chlorides; 0/NBD-taurine; 0/Nicotinic Acids; 0/Oxadiazoles; 104778-51-0/2,4,6-trichlorobenzenesulfonate; 107-35-7/Taurine; 4394-00-7/Niflumic Acid; 70-34-8/Dinitrofluorobenzene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular mechanisms of band 3 inhibitors. 2. Channel blockers.
Next Document:  Response of the local heme environment of (carbonmonoxy)hemoglobin to protein dehydration.